This article, published in the journal Vaccine, reviews the incidence of vaccine-serotype invasive pneumococcal disease and other pneumococcal-associated respiratory tract diseases following the routine use of the seven-valent pneumococcal conjugate vaccine, Prevenar™.

Author(s): Center KJ

Published: 2007

Resource types: Peer-reviewed journal

Diseases: Pneumococcus

Topics: Disease burden and surveillance; Disease/vaccine specific information

Regions: North America and Europe